-
SAB Biotherapeutics is going public as it continues testing its COVID-19 treatment.
-
A Sioux Falls-based company plans to go public by merging with a Florida company that it says will raise its enterprise value to $325 million. SAB…
-
More money is flowing to a South Dakota company that hopes to create a treatment for COVID-19.SAB Biotherapeutics in Sioux Falls is getting $57.5 million…
-
In The Moment ... August 21, 2020 Show 886 Hour 1SAB Biotherapeutics in Sioux Falls announced the first step in its trial of a COVID 19 therapeutic…
-
In The Moment ... April 10, 2020 Show 793 Hour 2The human body has its own, powerful immune response that fights off illness and disease. Scientists at…
-
A South Dakota company is working on a therapeutic to treat COVID 19 – the disease caused by the coronavirus. S-A-B Biotherapeutics has been working on…
-
In The Moment ... March 10, 2020 Show 770 Hour 1SDPB is bringing you the latest information on the coronavirus and COVID-19, including research into the…
-
Blaine Crissman is with South Dakota Equity Partners and Eddie Sullivan is with SAB Biotherapeutics. SAB Biotherapeutics is a clinical-stage…
-
Eddie Sulivan, SAB Biotherapeutics president and CEO, joined Innovation to discuss the recent advancements made by his company.SAB Biotherapeutics…
-
In The Moment ... June 8, 2018 Show 354 Hour 2The USD Discovery District has its first anchor tenant - SAB Biotherapeutics, Inc. SAB president, CEO and…